期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

载脂蛋白AⅠ的抗动脉粥样硬化功能研究进展 被引量：9

下载PDF
导出
摘要 载脂蛋白AⅠ是高密度脂蛋白的主要蛋白质组分,其脂质结合型和脂质游离型表现为不同的构象,在胆固醇代谢过程中发挥重要作用。动物实验及临床试验表明,载脂蛋白AⅠ及其重组体、模拟肽等类似物都具有显著的抗动脉粥样硬化作用,具有广阔的临床应用前景。
作者 张新波 王绿娅 陈保生
机构地区 南华大学心血管病研究所 首都医科大学附属北京安贞医院心肺血管疾病研究所动脉粥样硬化研究室 中国医学科学院基础医学研究所
出处 《中国动脉硬化杂志》 CAS CSCD 2007年第3期233-235,共3页 Chinese Journal of Arteriosclerosis
基金 国家重点基础研究"973"项目资助(G2000056902)
关键词 病理学与病理生理学 载脂蛋白AⅠ 动脉粥样硬化 高密度脂蛋白 重组体 载脂蛋白AⅠ MILANO
分类号 R363.2 [医药卫生—病理学]
  • 相关文献

参考文献23

  • 1[1]Goldberg U,Yaari S,Medalie JH.Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality.A 21-year follow-up of 8000 men[J].Arterioscler Thromb Vasc Biol,1997,17 (1):107-113.
  • 2庄一义.载脂蛋白A1和B的参考值及临床意义[J].中国动脉硬化杂志,2006,14(3):263-266. 被引量：35
  • 3[3]Frank PG,Marcel YL.Apolipoprotein A-I:structure-function relationships[J].J Lipid Res,2000,41 (6):853-872.
  • 4[4]Segrest JP,Jones MK,Klon AE,Sheldahl CJ,Hellinger M,De Loof H,et al.Adetailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein[J].J Biol Chem,1999,274 (45):31 755-758.
  • 5[5]Phillips JC,Wriggers W,Li Z,Jonas A,Schulten K.Predicting the structure of apolipoprotein A-I in reconstituted high-density lipoprotein disks[J].Biophys J,1997,73 (5):2 337-346.
  • 6[6]Klon AE,Jones MK,Segrest JP,Harvey SC.Molecular belt models for the apolipoprotein A-I paris and milano mutations[J].Biophys J,2000,79 (3):1679-685.
  • 7[7]Borhani DW,Engler JA,Brouillette CG.Crystallization of truncated human apolipoprotein A-I in a novel conformation[J].Acta Crystallogr D Biol Crystallogr,1999,55 (9):1 578-583.
  • 8[8]Borhani DW,Rogers DP,Engler JA,Brouillette CG.Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation[J].Proc Natl Acad Sci USA,1997,94 (23):12 291-296.
  • 9[9]Ajees AA,Anantharamaiah GM,Mishra VK,Hussain MM,Murthy HM.Crystal structure of human apolipoprotein A-I:Insights into its protective effect against cardiovascular diseases[J].Proc Natl Acad Sci USA,2006,103 (7):2 126-131.
  • 10[10]Pastore L,Belalcazar LM,Oka K,Cela R,Lee B,Chan L,et al.Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice[J].Gene,2004,327 (2):153-160.

二级参考文献18

  • 1杨昌国,李清华,许叶.载脂蛋白AI和B的免疫浊度自动分析法[J].临床检验杂志,1995,13(6):287-290. 被引量：9
  • 2王抒,李健斋,赵淑华,唐蔚青,褚德发,李培瑛,满咏,李红霞.血清载脂蛋白参考值[J].中华医学检验杂志,1996,19(6):343-348. 被引量：30
  • 3Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, Steiner E. Apolipoprotein B and A1 values in 147 576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials[J]. Clin Chem, 1998,44 (8):1641-649
  • 4Averina M, Nilssen O, Brenn T. Factora behind the increase in cardiovascular mortality in Russia: Apolipoprotein AⅠ and B distribution in the Arkhagelsk study 2000[J]. Clin Chem, 2004, 50(2):346-54
  • 5Bachorik PS, Lovejoy KL, Carroll MD, Johnson CL. Apolipoprotein B and AⅠ distributions in the United States, 1988-1991: results of the National Health and Nutrifion Examinafion Survey Ⅲ(NHANES Ⅲ)[J]. Clin Chem, 1997,43(12):2364-378
  • 6Contois JH, Mcnamara JR, Lammi-Keefe CJ, Wilson PWF, Massov T, Schaefer EJ. Reference intervals for plasma apolipoprotein A1 determined with a sfandardized commerercial immunoturbidimetric assay: result from the Framingham Offspring Study[J]. Clin Chem, 1996,42(4):507-514
  • 7Contois JH, Mcnamara JR, Lmmi-Keefe CJ, Wilson PWF, Massov T, Schaefer EJ. Reference intervals for plasma apolipoprotein B determined with a sfandardized commerercial immunoturbidimetric assay: result from the Framingham Offspring Study[J]. Clin Chem, 1996, 42(4):515-523
  • 8Walldius G, Junger I, Hgolme I. High apolipoprotein B, low apolipoprotein AⅠ, and improvement in the prediction of fatal myocardial infarction(AMORIS Study); a prospective study[J]. Lancet, 2001, 358(12):2025-033
  • 9Moss AJ, Goldstein RE, Marder VJ. Thrombogenic factors and recurrent coronary events[J]. Circulation, 1999,99(19):2517-522
  • 10Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR, et al. Apolipoprotein A1 and B levels and the risk of ischemic heart disease during a five year follow-up of men in the Quebec Cardiovascular study[ J]. Circulation, 1996, 94 (3) : 273-278

共引文献34

同被引文献83

引证文献9

二级引证文献20

中国动脉硬化杂志
2007年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部